Systemic AAV-Mediated β-Sarcoglycan Delivery Targeting Cardiac and Skeletal Muscle Ameliorates Histological and Functional Deficits in LGMD2E Mice
- Resource Type
- Article
- Source
- In
Molecular Therapy 5 April 2017 25(4):855-869 - Subject
- Language
- ISSN
- 1525-0016